{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:00:05Z","timestamp":1773050405456,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014643","name":"Baker Heart and Diabetes Institute","doi-asserted-by":"publisher","award":["Women in Science Grant"],"award-info":[{"award-number":["Women in Science Grant"]}],"id":[{"id":"10.13039\/501100014643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014643","name":"Baker Heart and Diabetes Institute","doi-asserted-by":"publisher","award":["Baker Fellowship"],"award-info":[{"award-number":["Baker Fellowship"]}],"id":[{"id":"10.13039\/501100014643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000971","name":"Diabetes Australia","doi-asserted-by":"crossref","award":["Y19G-BERB"],"award-info":[{"award-number":["Y19G-BERB"]}],"id":[{"id":"10.13039\/501100000971","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000971","name":"Diabetes Australia","doi-asserted-by":"crossref","award":["Y19G-BERB"],"award-info":[{"award-number":["Y19G-BERB"]}],"id":[{"id":"10.13039\/501100000971","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["102539 (Future Leader Fellowship)"],"award-info":[{"award-number":["102539 (Future Leader Fellowship)"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["Research Training Program scholarship"],"award-info":[{"award-number":["Research Training Program scholarship"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1078985"],"award-info":[{"award-number":["1078985"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1117835"],"award-info":[{"award-number":["1117835"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2017070"],"award-info":[{"award-number":["2017070"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00109-023-02397-2","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:04:14Z","timestamp":1700553854000},"page":"95-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology"],"prefix":"10.1007","volume":"102","author":[{"given":"Kate L.","family":"Weeks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kiriazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn D.","family":"Wadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma I.","family":"Masterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola M.","family":"Sergienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia J. A.","family":"Raaijmakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Trewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia A.","family":"Harmawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunes S.","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gregorevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea M. D.","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4534-0549","authenticated-orcid":false,"given":"Bianca C.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"issue":"14","key":"2397_CR1","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.jacc.2021.02.030","volume":"77","author":"I Cavallari","year":"2021","unstructured":"Cavallari I, Bhatt DL, Steg PG, Leiter LA, McGuire DK, Mosenzon O, Im K, Raz I, Braunwald E, Scirica BM (2021) Causes and risk factors for death in diabetes: a competing-risk analysis from the SAVOR-TIMI 53 trial. J Am Coll Cardiol 77(14):1837\u20131840","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2397_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34(1):29\u201334","journal-title":"Am J Cardiol"},{"issue":"11","key":"2397_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1042\/CS20210052","volume":"135","author":"D Prakoso","year":"2021","unstructured":"Prakoso D, Tate M, Blasio MJ, Ritchie RH (2021) Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives. Clin Sci 135(11):1369\u20131387","journal-title":"Clin Sci"},{"issue":"22","key":"2397_CR4","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1161\/CIRCULATIONAHA.119.040057","volume":"139","author":"GA Figtree","year":"2019","unstructured":"Figtree GA, R\u00e5dholm K, Barrett TD, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B (2019) Effects of canagliflozin on heart failure outcomes associated with preserved and reduced ejection fraction in type 2 diabetes mellitus. Circulation 139(22):2591\u20132593","journal-title":"Circulation"},{"issue":"10354","key":"2397_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","volume":"400","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, McMurray JJV, Solomon SD (2022) SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet 400(10354):757\u2013767","journal-title":"Lancet"},{"issue":"3","key":"2397_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5694\/mja2.51637","volume":"217","author":"JR Snaith","year":"2022","unstructured":"Snaith JR, Greenfield JR (2022) Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection? Med J Aust 217(3):126\u2013128","journal-title":"Med J Aust"},{"key":"2397_CR7","doi-asserted-by":"crossref","unstructured":"Karwi QG, Sun Q, Lopaschuk GD (2021) The contribution of cardiac fatty acid oxidation to diabetic cardiomyopathy severity. Cells 10(11)","DOI":"10.3390\/cells10113259"},{"issue":"1","key":"2397_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0806-4","volume":"18","author":"QG Karwi","year":"2019","unstructured":"Karwi QG, Zhang L, Wagg CS, Wang W, Ghandi M, Thai D, Yan H, Ussher JR, Oudit GY, Lopaschuk GD (2019) Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction. Cardiovasc Diabetol 18(1):1","journal-title":"Cardiovasc Diabetol"},{"key":"2397_CR9","doi-asserted-by":"crossref","unstructured":"Wang W, Zhang L, Battiprolu PK, Fukushima A, Nguyen K, Milner K, Gupta A, Altamimi T, Byrne N, Mori J, Alrob OA, Wagg C, Fillmore N, Wang S-h, Liu DM, Fu A, Lu JY, Chaves M, Motani A, Ussher JR, Reagan JD, Dyck JRB, Lopaschuk GD (2019) Malonyl CoA decarboxylase inhibition improves cardiac function post-myocardial infarction. JACC: Basic Transl Sci 4(3):385\u2013400","DOI":"10.1016\/j.jacbts.2019.02.003"},{"issue":"10","key":"2397_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.119.043319","volume":"142","author":"D Shao","year":"2020","unstructured":"Shao D, Kolwicz SC, Wang P, Roe ND, Villet O, Nishi K, Hsu Y-WA, Flint GV, Caudal A, Wang W, Regnier M, Tian R (2020) Increasing fatty acid oxidation prevents high-fat diet\u2013induced cardiomyopathy through regulating Parkin-mediated mitophagy. Circulation 142(10):983\u2013997","journal-title":"Circulation"},{"issue":"6","key":"2397_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","volume":"111","author":"SC Kolwicz Jr","year":"2012","unstructured":"Kolwicz SC Jr, Olson DP, Marney LC, Garcia-Menendez L, Synovec RE, Tian R (2012) Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 111(6):728\u2013738","journal-title":"Circ Res"},{"key":"2397_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2016.09.001","volume":"100","author":"YS Choi","year":"2016","unstructured":"Choi YS, de Mattos ABM, Shao D, Li T, Nabben M, Kim M, Wang W, Tian R, Kolwicz SC Jr (2016) Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion. J Mol Cell Cardiol 100:64\u201371","journal-title":"J Mol Cell Cardiol"},{"issue":"24","key":"2397_CR13","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104(24):2923\u20132931","journal-title":"Circulation"},{"issue":"6","key":"2397_CR14","doi-asserted-by":"publisher","first-page":"e1781","DOI":"10.1542\/peds.2013-1105","volume":"133","author":"JR Wiles","year":"2014","unstructured":"Wiles JR, Leslie N, Knilans TK, Akinbi H (2014) Prolonged QTc interval in association with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 133(6):e1781\u20131786","journal-title":"Pediatrics"},{"key":"2397_CR15","doi-asserted-by":"publisher","DOI":"10.4061\/2009\/281389","volume":"2009","author":"M Marci","year":"2009","unstructured":"Marci M, Ajovalasit P (2009) Medium-chain Acyl-CoA dehydrogenase deficiency in an infant with dilated cardiomyopathy. Cardiol Res Pract 2009:281389","journal-title":"Cardiol Res Pract"},{"key":"2397_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/ATVBAHA.109.201988","volume":"30","author":"RCY Lin","year":"2010","unstructured":"Lin RCY, Weeks KL, Gao X-M, Williams RBH, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman R, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du X-J, McMullen JR (2010) PI3K(p110a) protects against myocardial infarction-induced heart failure\/ Identification of PI3K-regulated miRNAs and mRNAs. Arterioscler Thromb Vasc Biol 30:724\u2013732","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2397_CR17","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1007\/s00125-012-2720-0","volume":"55","author":"RH Ritchie","year":"2012","unstructured":"Ritchie RH, Love JE, Huynh K, Bernardo BC, Henstridge DC, Kiriazis H, Tham YK, Sapra G, Qin C, Cemerlang N, Boey EJ, Jandeleit-Dahm K, Du XJ, McMullen JR (2012) Enhanced phosphoinositide 3-kinase(p110alpha) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes. Diabetologia 55(12):3369\u20133381","journal-title":"Diabetologia"},{"issue":"3","key":"2397_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cardfail.2016.08.001","volume":"23","author":"I Saifudeen","year":"2017","unstructured":"Saifudeen I, Subhadra L, Konnottil R, Nair RR (2017) Metabolic modulation by medium-chain triglycerides reduces oxidative stress and ameliorates CD36-mediated cardiac remodeling in spontaneously hypertensive rat in the initial and established stages of hypertrophy. J Card Fail 23(3):240\u2013251","journal-title":"J Card Fail"},{"issue":"1","key":"2397_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11010-020-03925-1","volume":"476","author":"S Ismael","year":"2021","unstructured":"Ismael S, Nair RR (2021) Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line. Mol Cell Biochem 476(1):483\u2013491","journal-title":"Mol Cell Biochem"},{"key":"2397_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1042\/CS20171269","volume":"132","author":"BC Bernardo","year":"2018","unstructured":"Bernardo BC, Weeks KL, Pongsukwechkul T, Gao X, Kiriazis H, Cemerlang N, Boey EJ, Tham YK, Johnson CJ, Qian H, Du XJ, Gregorevic P, McMullen JR (2018) Gene delivery of medium chain acyl-coenzyme A dehydrogenase (MCAD) induces physiological cardiac hypertrophy and protects against pathological remodelling. Clin Sci 132:381\u2013397","journal-title":"Clin Sci"},{"issue":"3","key":"2397_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00125-021-05637-7","volume":"65","author":"KL Ho","year":"2022","unstructured":"Ho KL, Karwi QG, Connolly D, Pherwani S, Ketema EB, Ussher JR, Lopaschuk GD (2022) Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia 65(3):411\u2013423","journal-title":"Diabetologia"},{"issue":"1","key":"2397_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12944-018-0872-8","volume":"17","author":"W Li","year":"2018","unstructured":"Li W, Yao M, Wang R, Shi Y, Hou L, Hou Z, Lian K, Zhang N, Wang Y, Li W, Wang W, Jiang L (2018) Profile of cardiac lipid metabolism in STZ-induced diabetic mice. Lipids Health Dis 17(1):231","journal-title":"Lipids Health Dis"},{"issue":"19","key":"2397_CR23","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/cells11193117","volume":"11","author":"BC Bernardo","year":"2022","unstructured":"Bernardo BC, Yildiz GS, Kiriazis H, Harmawan CA, Tai CMK, Ritchie RH, McMullen JR (2022) In vivo inhibition of miR-34a modestly limits cardiac enlargement and fibrosis in a mouse model with established type 1 diabetes-induced cardiomyopathy, but does not improve diastolic function. Cells 11(19):3117","journal-title":"Cells"},{"key":"2397_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yjmcc.2020.11.004","volume":"151","author":"A Lother","year":"2021","unstructured":"Lother A, Bondareva O, Saadatmand AR, Pollmeier L, Hardtner C, Hilgendorf I, Weichenhan D, Eckstein V, Plass C, Bode C, Backs J, Hein L, Gilsbach R (2021) Diabetes changes gene expression but not DNA methylation in cardiac cells. J Mol Cell Cardiol 151:74\u201387","journal-title":"J Mol Cell Cardiol"},{"key":"2397_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.848364","volume":"13","author":"Y Xi","year":"2022","unstructured":"Xi Y, Chen D, Dong Z, Lam H, He J, Du K, Chen C, Guo J, Xiao J (2022) RNA sequencing of cardiac in a rat model uncovers potential target LncRNA of diabetic cardiomyopathy. Front Genet 13:848364","journal-title":"Front Genet"},{"issue":"6","key":"2397_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.mito.2013.05.001","volume":"13","author":"R Ferreira","year":"2013","unstructured":"Ferreira R, Guerra G, Padrao AI, Melo T, Vitorino R, Duarte JA, Remiao F, Domingues P, Amado F, Domingues MR (2013) Lipidomic characterization of streptozotocin-induced heart mitochondrial dysfunction. Mitochondrion 13(6):762\u2013771","journal-title":"Mitochondrion"},{"issue":"39","key":"2397_CR27","doi-asserted-by":"publisher","first-page":"29834","DOI":"10.1074\/jbc.M110.139493","volume":"285","author":"Y Wang","year":"2010","unstructured":"Wang Y, Mohsen AW, Mihalik SJ, Goetzman ES, Vockley J (2010) Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J Biol Chem 285(39):29834\u201329841","journal-title":"J Biol Chem"},{"issue":"2","key":"2397_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.pep.2004.06.021","volume":"37","author":"J Zeng","year":"2004","unstructured":"Zeng J, Li D (2004) Expression and purification of His-tagged rat mitochondrial medium-chain acyl-CoA dehydrogenase wild-type and Arg256 mutant proteins. Protein Expr Purif 37(2):472\u2013478","journal-title":"Protein Expr Purif"},{"issue":"1","key":"2397_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/bmmb.1994.1031","volume":"52","author":"P Bross","year":"1994","unstructured":"Bross P, Jensen TG, Andresen BS, Kjeldsen M, Nandy A, K\u00f8lvraa S, Ghisla S, Rasched I, Bolund L, Gregersen N (1994) Characterization of wild-type human medium-chain acyl-CoA dehydrogenase (MCAD) and mutant enzymes present in MCAD-deficient patients by two-dimensional gel electrophoresis: evidence for post-translational modification of the enzyme. Biochem Med Metab Biol 52(1):36\u201344","journal-title":"Biochem Med Metab Biol"},{"issue":"10","key":"2397_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1091\/mbc.E18-03-0155","volume":"29","author":"MM Course","year":"2018","unstructured":"Course MM, Scott AI, Schoor C, Hsieh CH, Papakyrikos AM, Winter D, Cowan TM, Wang X (2018) Phosphorylation of MCAD selectively rescues PINK1 deficiencies in behavior and metabolism. Mol Biol Cell 29(10):1219\u20131227","journal-title":"Mol Biol Cell"},{"issue":"2","key":"2397_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvn066","volume":"79","author":"JH Rennison","year":"2008","unstructured":"Rennison JH, McElfresh TA, Okere IC, Patel HV, Foster AB, Patel KK, Stoll MS, Minkler PE, Fujioka H, Hoit BD, Young ME, Hoppel CL, Chandler MP (2008) Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 79(2):331\u2013340","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2397_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12012-021-09706-6","volume":"22","author":"P Zhong","year":"2022","unstructured":"Zhong P, Peng J, Liu T, Ding HS (2022) AAV9-mediated cardiac CNTF overexpression exacerbated adverse cardiac remodeling in streptozotocin-induced type 1 diabetic models. Cardiovasc Toxicol 22(1):88\u201396","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"2397_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2337\/db11-0763","volume":"61","author":"M Meloni","year":"2012","unstructured":"Meloni M, Descamps B, Caporali A, Zentilin L, Floris I, Giacca M, Emanueli C (2012) Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 61(1):229\u2013240","journal-title":"Diabetes"},{"issue":"10","key":"2397_CR34","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.110.239111","volume":"108","author":"R Katare","year":"2011","unstructured":"Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G, Oikawa A, Cesselli D, Beltrami AP, Giacca M, Emanueli C, Madeddu P (2011) Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 108(10):1238\u20131251","journal-title":"Circ Res"},{"key":"2397_CR35","doi-asserted-by":"crossref","unstructured":"Tate M, Perera N, Prakoso D, Willis AM, Deo M, Oseghale O, Qian H, Donner DG, Kiriazis H, De Blasio MJ, Gregorevic P, Ritchie RH (2021) Bone morphogenetic protein 7 gene delivery improves cardiac structure and function in a murine model of diabetic cardiomyopathy. Front Pharmacol 12","DOI":"10.3389\/fphar.2021.719290"},{"issue":"12","key":"2397_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1042\/CS20170063","volume":"131","author":"D Prakoso","year":"2017","unstructured":"Prakoso D, De Blasio MJ, Qin C, Rosli S, Kiriazis H, Qian H, Du XJ, Weeks KL, Gregorevic P, McMullen JR, Ritchie RH (2017) Phosphoinositide 3-kinase (p110\u03b1) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction. Clin Sci (London) 131(12):1345\u20131360","journal-title":"Clinical Science (London)"},{"issue":"1","key":"2397_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/cvr\/cvab043","volume":"118","author":"D Prakoso","year":"2022","unstructured":"Prakoso D, Lim SY, Erickson JR, Wallace RS, Lees JG, Tate M, Kiriazis H, Donner DG, Henstridge DC, Davey JR, Qian H, Deo M, Parry LJ, Davidoff AJ, Gregorevic P, Chatham JC, De Blasio MJ, Ritchie RH (2022) Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart. Cardiovasc Res 118(1):212\u2013225","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2397_CR38","doi-asserted-by":"publisher","first-page":"H840","DOI":"10.1152\/ajpheart.00632.2019","volume":"318","author":"D Prakoso","year":"2020","unstructured":"Prakoso D, De Blasio MJ, Tate M, Kiriazis H, Donner DG, Qian H, Nash D, Deo M, Weeks KL, Parry LJ, Gregorevic P, McMullen JR, Ritchie RH (2020) Gene therapy targeting cardiac phosphoinositide 3-kinase (p110alpha) attenuates cardiac remodeling in type 2 diabetes. Am J Physiol Heart Circ Physiol 318(4):H840\u2013H852","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"2397_CR39","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","volume":"45","author":"A Kibel","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, Bacun T, Bosnjak I, Kibel D, Gros M (2017) Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res 45(6):1901\u20131929","journal-title":"J Int Med Res"},{"key":"2397_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-4939-8597-5_16","volume":"1816","author":"SC Chang","year":"2018","unstructured":"Chang SC, Ren S, Rau CD, Wang JJ (2018) Isoproterenol-induced heart failure mouse model using osmotic pump implantation. Methods Mol Biol 1816:207\u2013220","journal-title":"Methods Mol Biol"},{"key":"2397_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.014","volume":"175","author":"CM Madla","year":"2021","unstructured":"Madla CM, Gavins FKH, Merchant HA, Orlu M, Murdan S, Basit AW (2021) Let\u2019s talk about sex: Differences in drug therapy in males and females. Adv Drug Deliv Rev 175:113804","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2397_CR42","doi-asserted-by":"publisher","first-page":"H279","DOI":"10.1152\/ajpheart.00462.2022","volume":"324","author":"DH Chang","year":"2023","unstructured":"Chang DH, Dumanski SM, Ahmed SB (2023) Female sex-specific considerations to improve rigor and reproducibility in cardiovascular research. Am J Physiol Heart Circ Physiol 324(3):H279\u2013h287","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2397_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fphys.2018.00453","volume":"9","author":"R Toedebusch","year":"2018","unstructured":"Toedebusch R, Belenchia A, Pulakat L (2018) Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures. Front Physiol 9:453","journal-title":"Front Physiol"},{"issue":"2","key":"2397_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/diacare.2.2.120","volume":"2","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2(2):120\u2013126","journal-title":"Diabetes Care"},{"issue":"7533","key":"2397_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","volume":"332","author":"R Huxley","year":"2006","unstructured":"Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332(7533):73\u201378","journal-title":"BMJ"},{"issue":"8","key":"2397_CR46","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2337\/diacare.27.8.1947","volume":"27","author":"BE Suys","year":"2004","unstructured":"Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV, De Wolf D (2004) Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care 27(8):1947\u20131953","journal-title":"Diabetes Care"},{"issue":"9","key":"2397_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238727","volume":"15","author":"A Saadane","year":"2020","unstructured":"Saadane A, Lessieur EM, Du Y, Liu H, Kern TS (2020) Successful induction of diabetes in mice demonstrates no gender difference in development of early diabetic retinopathy. PLoS ONE 15(9):e0238727","journal-title":"PLoS ONE"},{"issue":"1","key":"2397_CR48","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1038\/s41598-018-20703-8","volume":"8","author":"C Chandramouli","year":"2018","unstructured":"Chandramouli C, Reichelt ME, Curl CL, Varma U, Bienvenu LA, Koutsifeli P, Raaijmakers AJA, De Blasio MJ, Qin CX, Jenkins AJ, Ritchie RH, Mellor KM, Delbridge LMD (2018) Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia. Sci Rep 8(1):2346","journal-title":"Sci Rep"},{"key":"2397_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.05.004","volume":"158","author":"J Ritterhoff","year":"2021","unstructured":"Ritterhoff J, McMillen TS, Villet O, Young S, Kolwicz SC Jr, Senn T, Caudal A, Tian R (2021) Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts. J Mol Cell Cardiol 158:1\u201310","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2397_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10258","volume":"7","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Anselmo AC, Mitragotri S (2022) Viral vector-based gene therapies in the clinic. Bioeng Transl Med 7(1):e10258","journal-title":"Bioeng Transl Med"},{"key":"2397_CR51","doi-asserted-by":"crossref","unstructured":"Tanne JH (2022) FDA approves $3.5m gene therapy for adults with haemophilia B. BMJ 379:o2858","DOI":"10.1136\/bmj.o2858"},{"issue":"3","key":"2397_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1051\/ject\/201850193","volume":"50","author":"MG Katz","year":"2018","unstructured":"Katz MG, Fargnoli AS, Yarnall C, Perez A, Isidro A, Hajjar RJ, Bridges CR (2018) Technique of complete heart isolation with continuous cardiac perfusion during cardiopulmonary bypass: new opportunities for gene therapy. J Extra Corpor Technol 50(3):193\u2013198","journal-title":"J Extra Corpor Technol"},{"key":"2397_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.omtm.2021.05.015","volume":"22","author":"YB Liu","year":"2021","unstructured":"Liu YB, Xu BC, Chen YT, Yuan X, Liu JY, Liu T, Du GZ, Jiang W, Yang Y, Zhu Y, Chen LJ, Ding BS, Wei YQ, Yang L (2021) Directed evolution of AAV accounting for long-term and enhanced transduction of cardiovascular endothelial cells. Mol Ther Methods Clin Dev 22:148\u2013161","journal-title":"Molecular Therapy - Methods & Clinical Development"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02397-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T03:02:19Z","timestamp":1705719739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02397-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02397-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3140983\/v1","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human subjects. All experiments using animals were conducted in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes (National Health & Medical Research Council of Australia, 8th Edition, 2013). All animal procedures and care were approved by the Alfred Research Alliance Animal Ethics Committee (Animal Ethics Committee Approved Project Number E\/1867\/2018\/B).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}